Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

RANKL helps regenerate lung cells, potentially aiding lung repair in diseases like COPD.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Specific mutations in a receptor cause facial abnormalities and hair loss.

AS101 reduces hair loss from chemotherapy.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Activin A promotes ear hair cell development, while follistatin delays it.

A(1-7) treatment reduces symptoms of lupus in mice.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Apremilast did not work for treating severe alopecia areata.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.